vitiligo

Pac man eat MA deal buy sell merger

Biotech

'Expect us to act' on M&A, AbbVie CEO says

AbbVie is teasing an aggressive M&A strategy should the right opportunity arise after the company lifted a $2 billion cap on business development.

Max Bayer Feb 9, 2023 2:29pm

photo of a pair of hands that show the skin condition vitiligo

Incyte scoops up preclinical biotech to widen vitiligo footprint

Oct 3, 2022 11:20am